Stay updated with breaking news from Strides Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries - read this article along with other careers information, tips and advice on BioSpace
Biolexis will launch AKS-452 as “AmbiVax-CTM” for global markets where the cold chain elimination would contribute to improving immunization coverage and reducing vaccine wastage
Massachusetts-based Akston Biosciences Corporation and Biolexis announced today that they have entered into a licensing, manufacturing, and commercialization agreement for Akston's AKS-452, a protein subunit COVID-19 vaccine. Under the agreement, Biolexis gains the right to manufacture and commercialize AKS-452 (branded as AmbiVax-CTM) in India and over 130 countries in Asia, Latin America, and Africa.
Procaps Group, a leading integrated international healthcare and pharmaceutical company, today announced the closing of an asset purchase agreement to acquire an 86,000ft² pharmaceutical production facility located in
A new drug application of Amphotericin B Liposome injection 50 mg filed by Nasdaq-listed Taiwanese clinical-stage specialty pharmaceutical firm TLC has been approved by the Central Drugs Standard Cont